FCI synthetic hydroxyapatite implants offer a cost effective and environmentally conservative alternative to natural hydroxyapatite.
• Indicated for enucleation and evisceration
• Made of totally synthetic hydroxyapatite
• Porosity range: 300 – 500μm
• Sterile
The hydroxyapatite is Class IIb medical devices manufactured by FCI S.A.S. – Notified Body: GMED CE n°0459.
No related case studies found.
| SKU | Designation | Size | Material | Packaging |
|---|---|---|---|---|
| S6.2010 | HA orbital implant | 10 mm | HA | Box of 1 |
| S6.2012 | HA orbital implant | 12 mm | HA | Box of 1 |
| S6.2014 | HA orbital implant | 14 mm | HA | Box of 1 |
| S6.2016 | HA orbital implant | 16 mm | HA | Box of 1 |
| S6.2018 | HA orbital implant | 18 mm | HA | Box of 1 |
| S6.2020 | HA orbital implant | 20 mm | HA | Box of 1 |
| S6.2022 | HA orbital implant | 22 mm | HA | Box of 1 |
